<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T20:55:27Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/61742" metadataPrefix="didl">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/61742</identifier><datestamp>2025-02-19T12:04:18Z</datestamp><setSpec>com_10324_40357</setSpec><setSpec>com_10324_952</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_40358</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2023-09-21T12:39:24Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10324_61742">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10324/61742</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>CD47 binding on vascular endothelial cells inhibits IL-17-mediated leukocyte adhesion</dc:title>
<dc:creator>Soriano Romani, Laura</dc:creator>
<dc:creator>Mir, Fayaz A.</dc:creator>
<dc:creator>Singh, Niharika</dc:creator>
<dc:creator>Chin, Ian</dc:creator>
<dc:creator>Hafezi Moghadam, Ali</dc:creator>
<dc:creator>Masli, Sharmila</dc:creator>
<dc:subject>Inflammation</dc:subject>
<dc:subject>Inflamación</dc:subject>
<dc:subject>Eye - Diseases</dc:subject>
<dc:subject>Ojos - Enfermedades</dc:subject>
<dc:subject>Ojo - Inflamación</dc:subject>
<dc:subject>Chronic inflammation</dc:subject>
<dc:subject>Leucocytes</dc:subject>
<dc:subject>Endothelial cells</dc:subject>
<dc:subject>Endotelio vascular</dc:subject>
<dc:subject>Cell Biology</dc:subject>
<dc:subject>Cell adhesion</dc:subject>
<dc:subject>Ophthalmology</dc:subject>
<dc:description>Producción Científica</dc:description>
<dc:description>To address the conflicting role of thrombospondin (TSP)-1 reported in acute and chronic pathologies, this study investigated the role of TSP-1 in regulating leukocyte recruitment and regulation of VCAM-1 expression using mouse models of uveitis. The spontaneously increased VCAM-1 expression and leukocyte adhesion in retinas of TSP-1-deficient mice suggested a TSP-1-mediated regulation of VCAM-1 expression. In a chronic uveitis model, induced by immunizing wild-type mice with specific interphotoreceptor retinoid-binding protein (IRBP) peptide, topically applied TSP-1-derived CD47-binding peptide significantly reduced the clinical disease course and retinal leukocyte adhesion as compared to the control peptide-treated group. In contrast, in LPS-mediated acute uveitis, TSP-1 deficiency significantly reduced the retinal leukocyte adhesion. The results of our in vitro study, using vascular endothelial cell (EC) cultures, demonstrate that unlike TNF-α, VCAM-1 expression induced by IL-17 is associated with a reduced expression of endogenous TSP-1. Such reduced endogenous TSP-1 expression in IL-17-stimulated ECs helps limit the CD36-mediated increased VCAM-1 expression, while favoring CD47-mediated inhibition of VCAM-1 expression and leukocyte adhesion. Thus, our study identifies TSP-1:CD47 interaction as a molecular pathway that modulates IL-17-mediated VCAM-1 expression, contributing to its anti-inflammatory effect in chronic inflammatory conditions.</dc:description>
<dc:date>2023-09-21T12:39:24Z</dc:date>
<dc:date>2023-09-21T12:39:24Z</dc:date>
<dc:date>2022</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>International Journal of Molecular Sciences, 2022, Vol. 23, Nº. 10, 5705</dc:identifier>
<dc:identifier>1422-0067</dc:identifier>
<dc:identifier>https://uvadoc.uva.es/handle/10324/61742</dc:identifier>
<dc:identifier>10.3390/ijms23105705</dc:identifier>
<dc:identifier>5705</dc:identifier>
<dc:identifier>10</dc:identifier>
<dc:identifier>International Journal of Molecular Sciences</dc:identifier>
<dc:identifier>23</dc:identifier>
<dc:identifier>1422-0067</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://www.mdpi.com/1422-0067/23/10/5705</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>© 2022 The Authors</dc:rights>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:publisher>MDPI</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10324_61742_1">
<d:Resource ref="https://uvadoc.uva.es/bitstream/10324/61742/1/CD47-Binding-on-Vascular-Endothelial-Cells.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>